Reference

Adverse Event Fields

The fields that carry the meaning in a drug adverse event report, as defined in openFDA’s field reference.

Report Fields

safetyreportid

The report’s unique ID.

receivedate

When FDA first received the report. If the report was updated later, this stays the date of the first version.

receiptdate

When FDA received the most recent information in the report.

serious

1 if the event led to death, a life-threatening condition, hospitalisation, disability, a congenital anomaly or another serious condition. 2 if not.

seriousnessdeath

1 if the event resulted in death. Otherwise the field is absent.

primarysource.qualification

Who originally reported it: 1 physician, 2 pharmacist, 3 other health professional, 4 lawyer, 5 consumer.

duplicate

1 if earlier versions of the report exist. openFDA shows only the latest version.

Drug Fields

patient.drug

Every drug in the report, each with a drugcharacterization: 1 suspect, 2 concomitant (taken alongside), 3 interacting. FDA doesn’t validate these roles.

patient.drug.medicinalproduct

The drug name as reported. It isn’t standardised and can contain misspellings.

patient.drug.openfda

Names and identifiers that openFDA has matched to official product data, such as generic_name and brand_name. Search these, not medicinalproduct.

Reaction Fields

patient.reaction.reactionmeddrapt

Each reaction as a MedDRA term, in British spelling, so diarrhea appears as “diarrhoea”.

patient.reaction.reactionoutcome

1 recovered, 2 recovering, 3 not recovered, 4 recovered with lasting effects, 5 fatal, 6 unknown.

Annotated Example

"safetyreportid": "26561852", 1 "receivedate": "20260401", 2 "serious": "2", 3 "patient": { "reaction": [ { "reactionmeddrapt": "Throat irritation", "reactionoutcome": "6" }, { "reactionmeddrapt": "Dysphonia", "reactionoutcome": "6" } ], "drug": [ { "medicinalproduct": "TYVASO DPI", "drugcharacterization": "1" }, 4 { "medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2" }, { "medicinalproduct": "FAMOTIDINE", "drugcharacterization": "2" } 5 ] }
  1. 1The report's unique ID.
  2. 2First received by FDA on April 1, 2026.
  3. 32 means the event was not serious.
  4. 41 marks the suspect drug, here TYVASO DPI (treprostinil).
  5. 52 marks a concomitant drug. A search for famotidine returns this report, even though famotidine is not the suspect.

Report 26561852, trimmed from a live response captured October 29, 2026. Every value shown was checked against the API.

Warning

A search for a drug name returns every report that mentions it, whatever its role. Before attributing a reaction to the drug you searched for, check its drugcharacterization in each result.